SCHEMBL17380554

SCHEMBL17380554

CC(C)(C)OC(=O)N1Cc2cn(S(=O)(=O)C3CCOC3)nc2C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 3/20 0.36
CRBN Q96SW2 3/20 0.36
NR1H2 P55055 1/20 0.36
SLC34A1 Q06495 1/20 0.36
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NAMPT P43490 2/20 0.35
RECQL P46063 1/20 0.35
MTOR P42345 4/20 0.35
PIK3CA P42336 3/20 0.35
HDAC1 Q13547 1/20 0.34
MAPT P10636 1/20 0.34
SCN9A Q15858 1/20 0.33
ESR2 Q92731 1/20 0.33
PIK3CD O00329 1/20 0.33
PIK3R2 O00459 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PIK3R5 Q8WYR1 1/20 0.33
PIK3R3 Q92569 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18788487 1.00 DDB1 (0.36) DDB1CRBNNR1H2SLC34A1USP2
SCHEMBL28037308 0.91 NAMPT (0.37) DDB1CRBNNR1H2SLC34A1USP2
SCHEMBL823793 0.88 HDAC1 (0.41) DDB1CRBNNR1H2SLC34A1NAMPT
SCHEMBL826919 0.86 NAMPT (0.39) DDB1CRBNNR1H2SLC34A1NAMPT
SCHEMBL20483907 0.83 USP9X (0.38) NAMPT
SCHEMBL14358443 0.80 HDAC1 (0.40) DDB1CRBNNR1H2SLC34A1NAMPT
SCHEMBL19203380 0.79 USP2 (0.45) NR1H2USP2SMN1; SMN2NAMPTRECQL
SCHEMBL17380568 0.78 HDAC1 (0.39) DDB1CRBNNR1H2SLC34A1NAMPT
SCHEMBL20392817 0.74 HDAC1 (0.44) DDB1CRBNNR1H2SLC34A1USP2
SCHEMBL18376191 0.74 NR1H2 (0.46) DDB1CRBNNR1H2USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170121338-A1 AMINO PRYAN RING DERIVATIVE AND COMPOSITION AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD (CN) 2017-05-04 US disclosed
US-20170121338-A1 AMINO PRYAN RING DERIVATIVE AND COMPOSITION AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD (CN) 2017-05-04 US disclosed
US-20170121338-A1 AMINO PRYAN RING DERIVATIVE AND COMPOSITION AND USE THEREOF SICHUAN HAISCO PHARMACEUTICAL CO., LTD (CN) 2017-05-04 US disclosed
CN-105518008-A Amino pyranoid ring derivative and composition and use thereof SICHUAN HAISCO PHARMACEUTICAL CO LTD 2016-04-20 CN disclosed
WO-2015192701-A1 AMINO PYRANOID RING DERIVATIVE AND COMPOSITION AND USE THEREOF 四川海思科制药有限公司 2015-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170121338-A1 AMINO PRYAN RING DERIVATIVE AND COMPOSITION AND USE THEREOF DPP4, DPP8, DPP3 DDB1 2091/4885CRBN 2487/4885NR1H2 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.